Pacific Shuanglin - Public Comps and Valuation Multiples

Pacific Shuanglin Overview

About Pacific Shuanglin

Pacific Shuanglin Bio-pharmacy Co Ltd is engaged in the research, development, production, and marketing of blood products.

Founded

1993

HQ

Employees

2.8K+

Website

999yichun.cn

Sectors

Biopharmaceuticals
BioTech

Financials

LTM Revenue $395M

LTM EBITDA $148M

EV

$2.0B

Valuation Multiples

Multiples.vc

Valuation Multiples for 15K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Browse Valuation Multiples

Pacific Shuanglin Financials

As of November 2025, Pacific Shuanglin reported last 12-month revenue of $395M and EBITDA of $148M.

In the same period, Pacific Shuanglin generated $192M in LTM gross profit and $107M in net income.

See Pacific Shuanglin valuation multiples based on analyst estimates

Pacific Shuanglin P&L

In the most recent fiscal year, Pacific Shuanglin reported revenue of $375M and EBITDA of $138M.

Pacific Shuanglin expects next 12-month revenue of XXX and NTM EBITDA of XXX

See Pacific Shuanglin valuation multiples based on analyst estimates

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Revenue	$395M	XXX	$375M	XXX	XXX	XXX
Gross Profit	$192M	XXX	$184M	XXX	XXX	XXX
Gross Margin	49%	XXX	49%	XXX	XXX	XXX
EBITDA	$148M	XXX	$138M	XXX	XXX	XXX
EBITDA Margin	37%	XXX	37%	XXX	XXX	XXX
EBIT	$120M	XXX	$114M	XXX	XXX	XXX
EBIT Margin	30%	XXX	30%	XXX	XXX	XXX
Net Profit	$107M	XXX	$105M	XXX	XXX	XXX
Net Margin	27%	XXX	28%	XXX	XXX	XXX
Net Debt	XXX	XXX	n/a	XXX	XXX	XXX

Financial data powered by Morningstar, Inc.

.seo-only-financials-wrapper { position: static; left: auto; width: auto; height: auto; overflow: visible; }

Financial performance metrics for Pacific Shuanglin including revenue, profitability, and margin analysis across different time periods. The company reported last twelve months revenue of $395M. EBITDA for the last twelve months was $148M. In the most recent fiscal year, Pacific Shuanglin achieved $375M in revenue and $138M in EBITDA.
Financial Metric	Last Twelve Months (LTM)	Next Twelve Months (NTM)	Most Recent Fiscal Year	Current Fiscal Year (2025)	Next Fiscal Year (2026)	Two Years Forward (2027)
Total Revenue	$395M	Analyst estimates available to subscribers	$375M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Gross Profit	$192M	Analyst estimates available to subscribers	$184M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Gross Profit Margin	48.5% gross margin	Analyst estimates available to subscribers	49.1% gross profit margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBITDA (Earnings Before Interest, Taxes, Depreciation, Amortization)	$148M	Analyst estimates available to subscribers	$138M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBITDA Margin	37.5% EBITDA margin	Analyst estimates available to subscribers	36.9% EBITDA margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBIT (Earnings Before Interest and Taxes)	$120M	Analyst estimates available to subscribers	$114M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBIT Margin	30.3% EBIT margin	Analyst estimates available to subscribers	30.3% EBIT margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Income (Net Profit)	$107M	Analyst estimates available to subscribers	$105M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Profit Margin	27.2% net profit margin	Analyst estimates available to subscribers	28.1% net profit margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Debt Position	Detailed debt information available to subscribers	Detailed debt information available to subscribers	n/a	Detailed debt information available to subscribers	Detailed debt information available to subscribers	Detailed debt information available to subscribers

Financial Performance Summary for Pacific Shuanglin

This financial data table provides comprehensive performance metrics for Pacific Shuanglin, a company based in China. The metrics include revenue, profitability measures, and operational efficiency indicators across multiple time periods.

Recent Performance Highlights

Pacific Shuanglin generated $395M in revenue over the last twelve months.
The company achieved $148M in EBITDA over the last twelve months.
Gross profit for the last twelve months was $192M.
Net income over the last twelve months reached $107M.

Fiscal Year Performance

In the most recent fiscal year, Pacific Shuanglin reported $375M in total revenue.
Fiscal year EBITDA was $138M.
The company maintained a gross profit margin of 49.1% in the most recent fiscal year.
EBITDA margin for the fiscal year was 36.9%.
Net profit margin reached 28.1% in the most recent fiscal year.

This financial data is sourced from Morningstar, Inc. and represents the most recent available information for Pacific Shuanglin. Forward-looking estimates and detailed financial projections are available through our premium subscription service.

Pacific Shuanglin Stock Performance

Pacific Shuanglin has current market cap of CNY 14.1B (or $2.0B), and EV of CNY 13.9B (or $2.0B).

Market Cap Evolution

Pacific Shuanglin Stock Data

As of December 4, 2025, Pacific Shuanglin's stock price is CNY 15 (or $2).

See Pacific Shuanglin trading valuation data

EV	Market Cap	Price 1D	Price 1M	Price 3M	Price 12M	EPS
$2.0B	$2.0B	XXX	XXX	XXX	XXX	$0.11

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Start Free Trial

Pacific Shuanglin Valuation Multiples

Pacific Shuanglin's trades at 5.2x EV/Revenue multiple, and 14.2x EV/EBITDA.

See valuation multiples for Pacific Shuanglin and 15K+ public comps

Pacific Shuanglin Financial Valuation Multiples

As of December 4, 2025, Pacific Shuanglin has market cap of $2.0B and EV of $2.0B.

Equity research analysts estimate Pacific Shuanglin's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

Pacific Shuanglin has a P/E ratio of 18.5x.

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Market cap (current)	$2.0B	XXX	$2.0B	XXX	XXX	XXX
EV (current)	$2.0B	XXX	$2.0B	XXX	XXX	XXX
EV/Revenue	5.0x	XXX	5.2x	XXX	XXX	XXX
EV/EBITDA	13.2x	XXX	14.2x	XXX	XXX	XXX
EV/EBIT	16.4x	XXX	17.2x	XXX	XXX	XXX
EV/Gross Profit	10.2x	XXX	n/a	XXX	XXX	XXX
P/E	18.5x	XXX	18.9x	XXX	XXX	XXX
EV/FCF	n/a	XXX	-69.7x	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Pacific Shuanglin Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Start Free Trial

Pacific Shuanglin Margins & Growth Rates

Pacific Shuanglin's last 12 month revenue growth is 19%

Pacific Shuanglin's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $25K for the same period.

Pacific Shuanglin's rule of 40 is 55% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Pacific Shuanglin's rule of X is 85% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

See operational valuation multiples for Pacific Shuanglin and other 15K+ public comps

Pacific Shuanglin Operational Valuation Multiples

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Revenue Growth	19%	XXX	13%	XXX	XXX	XXX
EBITDA Margin	37%	XXX	37%	XXX	XXX	XXX
EBITDA Growth	21%	XXX	12%	XXX	XXX	XXX
Rule of 40	55%	XXX	56%	XXX	XXX	XXX
Bessemer Rule of X	XXX	XXX	85%	XXX	XXX	XXX
Revenue per Employee	XXX	XXX	$0.1M	XXX	XXX	XXX
Opex per Employee	XXX	XXX	$25K	XXX	XXX	XXX
S&M Expenses to Revenue	XXX	XXX	8%	XXX	XXX	XXX
G&A Expenses to Revenue	XXX	XXX	n/a	XXX	XXX	XXX
R&D Expenses to Revenue	XXX	XXX	2%	XXX	XXX	XXX
Opex to Revenue	XXX	XXX	19%	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics

Pharma Analytics

Private Equity

ERP Software

Developer Tools

Consumer SaaS

Streaming Platforms

Explore Valuation Multiples by Industry

Start Free Trial